View full meeting coverage »

Eyetube Meeting Coverage:

Retina Updates Spring 2020

 

Editorially Independent Content, Financially Supported by

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

PALADIN Study in Diabetic Eye Disease

  Channels: Retina | Posted 5/13/2020

Victor H. Gonzalez, MD, discusses the PALADIN study, an ongoing phase 4 study evaluating the safety and efficacy of the fluocinolone acetonide intravitreal implant 0.19 mg (Iluvien, Alimera Sciences) as used in the real world in patients with diabetic eye disease. Dr. Gonzalez shares data regarding visual function, anatomic measures, and rates of rescue treatment from a 24-month readout.

Clinical Trials • diabetic eye disease • fluocinolone acetonide implant • Retinal Implants • retina-meeting-recap


5 / 10 Series: Retina Updates Spring 2020


These programs are not affiliated with the official program of ARVO 2020.